Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes
The L1 gene of human papillomavirus type 16 (HPV- 16) driven by the vaccinia virus major late 4b gene promoter has been inserted into three different sites of the vaccinia virus genome. Insertion into the thymidine kinase (TK) gene was achieved by selection of TK− mutants in BUdR on TK− cells. Insertion into two vaccinia virus serine protease inhibitor (serpin) genes was achieved by co-insertion of the Escherichia coli xanthine guanine phosphoribosyltransferase gene linked to the vaccinia virus 7·5K promoter and selection of mycophenolic acid-resistant recombinant viruses. Each recombinant virus expressed a 57K L1 protein at similar levels and with similar kinetics. However, immunization of mice with these recombinant viruses induced different levels of antibody to the LI protein. Viruses lacking serpin genes B13R and B24R induced significantly higher antibody levels than did viruses lacking the TK gene. The presence of functional B13R and B24R gene products is therefore somehow immunosuppressive at least for antibody responses to the LI protein of HPV-16.
BenninkJ. R., YewdellJ. W., SmithG. L., MossB.1986; Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes. Journal of Virology 57:786–791
BoursnellM. E. G., FouldsI. J., CampbellJ. I., BinnsM. M.1988; Non-essential genes in the vaccinia virus HindIII K fragment: a gene related to serine protease inhibitors and a gene related to the 37K vaccinia virus major envelope antigen. Journal of General Virology 69:2995–3003
BrowneH. M., ChurcherM. J., StanleyM. A., SmithG. L., MinsonA. C.1988; Analysis of the LI gene product of human papillomavirus type 16 by expression in a vaccinia virus recombinant. Journal of General Virology 69:1263–1273
ChuaT. P., SmithC. E., ReithR. W., WilliamsonJ. D.1990; Inflammatory responses and the generation of chemoattractant activity in cowpox virus-infected tissues. Immunology 69:202–208
CouparB. E. H., AndrewM. E., BothG. W., BoyleD. B.1986; Temporal regulation of influenza haemagglutinin expression in vaccinia virus recombinants and effects on the immune response. European Journal of Immunology 16:1479–1487
DürstM., GissmannL., IkenburgH., zur HausenH.1983; A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proceedings of the National Academy of Sciences, U.S.A 80:3812–3815
DürstM., KleinheinzA., HotzM., GissmannL.1985; The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. Journal of General Virology 66:1515–1522
GouldK., GossinsJ., BastinJ., BrownleeG. G., TownsendA. R. M.1989; A 15 amino acid fragment of influenza virus nucleoprotein synthesised in the cytoplasm is presented to class 1-restricted cytotoxic T lymphocytes. Journal of Experimental Medicine 170:1051–1056
KotwalG. J., MossB.1989; Vaccinia virus encodes two proteins that are structurally related to members of the plasma serine protease inhibitor superfamily. Journal of Virology 63:600–606
MackettM., SmithG. L., MossB.1984; General method for the production and selection of vaccinia virus recombinants expressing foreign genes. Journal of Virology 49:857–864
MackettM., SmithG. L., MossB.1985a; The construction and characterization of vaccinia virus recombinants expressing foreign genes. In DNA Cloning: A Practical Approach2 pp. 191–211GloverD. M. Edited by Oxford: IRL Press;
MackettM., YilmaT., RoseJ., MossB.1985b; Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. Science 227:422–435
McleanC. S., ChurcherM. J., MeinkeJ., SmithG. L., HigginsG., StanleyM., MinsonA. C.1990; Production and characterisation of a monoclonal antibody to human papillomavirus type 16 using a recombinant vaccinia virus. Journal of Clinical Pathology 43:488–492
McmichaelA. J., MichieC. A., GotchF. M., SmithG. L., MossB.1986; Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes. Journal of General Virology 67:719–726
PalumboG. J., PickupD. J., FredricksonT. N., McintyreL. J., BullerR. M. L.1989; Inhibition of an inflammatory response is mediated by a 38-kDa protein of cowpox virus. Virology 172:262–273
PaolettiE., LipinskasB. R., SamsonoffC., MercerS., PanicaliD.1984; Construction of live vaccinia viruses using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D. Proceedings of the National Academy of Sciences, U.S.A 81:193–197
PickupD. J., InkB. S., HuW., RayC. A., JoklikW. K.1986; Hemorrhage in lesions caused by cowpox virus is inhibited by a viral protein that is related to plasma protein inhibitors of serine proteases. Proceedings of the National Academy of Sciences, U.S.A 83:7698–7702
RohrmannG., YuenL., MossB.1986; Transcription of vaccinia virus early genes by enzymes isolated from vaccinia virions terminates downstream of a regulatory sequence. Cell 46:1029–1035
RoselJ., MossB.1985; Transcriptional and translational mapping and nucleotide sequence of a vaccinia virus gene encoding the precursor of the major core polypeptide 4b. Journal of Virology 56:830–838
SmithG. L., MurphyB. R., MossB.1983b; Construction and characterization of an infectious vaccinia virus recombinant that expresses the influenza virus hemagglutinin and induces resistance to influenza virus infection in hamsters. Proceedings of the National Academy of Sciences, U.S.A 80:7155–7159
SmithG. L., HowardS. T., ChanY. S.1989; Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors. Journal of General Virology 70:2333–2343
TownsendA. R. M., BastinJ., GouldK., BrownleeG. G., AndrewA., BoyleD. B., ChanY. S., SmithG. L.1988; Defective presentation to class I restricted CTL in vaccinia infected cells is overcome by enhanced degradation of antigen. Journal of Experimental Medicine 168:1211–1224
WiktorJ. J., MacfarlanR. I., ReaganK. H., DietzscholdB., CurtisP. J., WunnerW. H., KienyM. P., LatheR., LecocqJ. P., MackettM., MossB., KoprowskiH.1984; Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene. Proceedings of the National Academy of Sciences, U.S.A 81:7194–7198
YewdellJ. W., BenninkJ. R., SmithG. L., MossB.1985; Influenza A virus nucleoprotein is a major target antigen for cross reactive anti-influenza A virus cytotoxic T lymphocytes. Proceedings of the National Academy of Sciences, U.S.A 82:1785–1789
YuenL., MossB.1987; Oligonucleotide sequence signalling transcriptional termination of vaccinia virus early genes. Proceedings of the National Academy of Sciences, U.S.A 84:6417–6421
Increased antibody responses to human papillomavirus type 16 L1 protein expressed by recombinant vaccinia virus lacking serine protease inhibitor genes